Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Jungle Junction - 206384

Overview

The Therapeutic Goods Act 1989 was enacted by the Parliament of Australia to regulate the safety, quality, and efficacy of therapeutic goods, including medicines, medical devices, and other related products available in the Australian market. This legislation was introduced to address the need for a comprehensive regulatory framework to ensure that therapeutic goods meet the necessary standards for public health and safety. The Act provides mechanisms for the assessment, registration, and monitoring of therapeutic goods to prevent the distribution and use of unsafe or ineffective products. The cancellation of entries from the Australian Register of Therapeutic Goods, as demonstrated in this Gazette, is one such mechanism employed to uphold these standards by removing non-compliant products from the market. The policy objective underpinning this action is to protect public health by ensuring that only therapeutic goods that meet the required safety, quality, and efficacy standards are available for use in Australia.

Scope and Application

The Therapeutic Goods Act 1989 governs the regulation of therapeutic goods in Australia, including medical devices, and applies to a wide range of entities and individuals involved in the manufacture, supply, or advertising of these goods. This Act imposes obligations on sponsors, manufacturers, importers, and other parties to ensure that therapeutic goods meet safety, quality, and performance standards. The Act applies to the entire Commonwealth of Australia, extending its jurisdiction to all states and territories. The Act's scope encompasses various medical devices, and the Therapeutic Goods Administration (TGA) maintains the Australian Register of Therapeutic Goods (ARTG), which includes listings of approved therapeutic goods. The Act provides for the cancellation of entries from the ARTG when certain conditions are not met, such as failure to comply with information or documentation requirements. Subordinate instruments and regulations may further define the application and enforcement of the Act, ensuring comprehensive oversight of the therapeutic goods market. In the specific instance of the cancellation of the entry for the stimulator, electrical, analgesic, peripheral nerve, transcutaneous from the ARTG, the Act's application is evident in the TGA's enforcement of compliance with statutory requirements. The cancellation was prompted by the sponsor's failure to comply with a notice under section 41JA of the Act, which mandates the provision of relevant information or documents regarding the medical device. As a result, the delegate of the Secretary of the Department of Health and Ageing exercised their authority under section 41GN(1)(c) of the Act to remove the entry from the ARTG. This action underscores the importance of adherence to regulatory requirements and highlights the TGA's commitment to maintaining the integrity of the therapeutic goods market. The decision to cancel the entry from the ARTG affects the sponsor and manufacturer, impacting their ability to supply the listed medical device within Australia.

Key Provisions

The Therapeutic Goods Act 1989 (the Act) includes various provisions for the regulation of therapeutic goods, including medical devices, within Australia. Section 41GP allows for the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG) under specific circumstances, as demonstrated in this legislative instrument (section 41GP). The cancellation pertains to the removal of an entry for a particular type of medical device from the ARTG. In this instance, the entry for a "Stimulator, electrical, analgesic, peripheral nerve, transcutaneous" has been cancelled (section 41GP(1)). Under the Act, manufacturers and sponsors of medical devices are required to ensure that their products meet certain standards and are safe for use. They must also provide accurate and complete information about their products to the Therapeutic Goods Administration (TGA). Specifically, section 41JA of the Act mandates that if the Secretary issues a notice to a person requiring them to provide information or documents relating to a medical device, the person must comply with that notice within the specified timeframe. Failure to comply with such a notice can result in the cancellation of the device's entry from the ARTG (section 41GN(1)(c)). In this case, the manufacturer, Sing Nay Cird International Co Ltd, was given a notice under section 41JA of the Act to provide information or documents relating to the stimulator device. However, the manufacturer failed to comply with this notice within the required 10 working days, leading to the cancellation of the device's entry from the ARTG (section 41GN(1)(c)). The decision to cancel the entry was made by Rodolfo Ferrari, acting as the delegate of the Secretary of the Department of Health and Ageing (section 41GP(1)). Failure to comply with the obligations and requirements set out in the Therapeutic Goods Act 1989 can result in various consequences. Under section 41GN(1)(c) of the Act, the delegate of the Secretary of the Department of Health and Ageing has the authority to cancel the entry of a kind of medical device from the ARTG if the manufacturer fails to provide the required information or documents within the specified timeframe. This cancellation can have significant implications for the manufacturer and the availability of the medical device in the Australian market (section 41GP(1)). Additionally, there may be potential civil or criminal liabilities for the manufacturer or sponsor if they are found to have intentionally or negligently provided misleading or false information about their medical device (section 41JA and 41GN).